Akynezo

Helsinn Group Announces FDA approval of IV Formulation of Akynzeo for Chemotherapy Induced Nausea and Vomiting Configure
CP Wire
Fri, 04/20/18 - 10:02 am
Helsinn Group
FDA
Akynezo
chemotherapy-induced nausea and vomiting